Background: Impulsivity is considered a core clinical feature in borderline
Introduction
Borderline personality disorder (BPD) is characterised by problematic clinical features such as impulsivity, emotional instability, interpersonal difficulties, and cognitive dysfunctional process (American Psychiatric Association, 2013) . These clinical features have a strong detrimental impact on general functioning (Skodol et al., 2002) , treatment compliance (Chiesa, Martino, & Pozzi, 2010; Martino, Menchetti, Pozzi, & Berardi, 2012) , physical health status (Douzenis, Tsopelas, & Tzeferakos, 2012) , and relationships with relatives and peers (Martino et al., 2014) . Impulsivity in BPD is thought to be a central symptom and key component of the disorder (Moeller, Barratt, Dougherty, Schmitz, & Swann, 2001 ). The clinical concept of impulsivity is diffuse and is usually measured by self-report instruments (Lieb, Zanarini, Schmahl, Linehan, & Bohus, 2004) . Research has shown that impulsivity is higher in BPD compared with healthy controls (Berlin, Rolls, & Iversen, 2005; Domes et al., 2006; Kunert, Druecke, Sass, & Herpertz, 2003; Paris et al., 2004; Rentrop et al., 2008) . In contrast, neuropsychological and behavioural measures of impulsive behaviours overlap only partially with impulsivity as assessed by self-report. Behavioural impulsivity is measured by a variety of experimental paradigms, such as response inhibition, cognitive and interference inhibition, and decisional impulse control. Evidence appears to suggest (Le Gris, Links, van Reekum, Tannock, & Toplak, 2012) that behavioural response inhibition, mainly measured by simple Go/no-go and Stop-signal paradigms, is only weakly affected in BPD. Conversely, cognitive and interference inhibition appears to be affected in BPD (Sebastian, Jacob, Lieb, & Tüscher, 2013) , but the results are mixed and currently remain rather inconclusive.
The discrepancy between the clinical perception of impulsivity and data from laboratory research can be explained (at least in part) by the variety of measures employed in research, such as self-report, behavioural, and neurophysiological measures. A further explanation lies in the lack of a unified definition of impulsivity which has come to include distractibility and a short attention span, the need to seek stimulation and novelty, susceptibility to boredom, acting without forethought, and emotionally triggered rash action (Depue & Collins, 1999; Whiteside & Lynam, 2001; Zapolski, Settles, Cyders, & Smith, 2010) .
To complicate further the picture, it has been argued that the aforementioned discrepancy may be due to affective dysregulation (Clarkin, Hull, & Hurt, 1993) , which is a central feature in BPD. This may drive problematic behaviours, such as substance use, as a means of reducing such unpleasant emotions, resulting in increased impulsivity and behavioural dyscontrol (Chmielewski, Bagby, Quilty, Paxton, & McGee Ng, 2011; Linehan, 1993; Selby & Joiner, 2009) .
In support of this view, research has shown that patients with BPD present with high rates (ranging from 57 to 78%) of co-occuring substance-related and addictive disorders (SRADs) (Bornovalova, Lejuez, Daughters, Zachary Rosenthal, & Lynch, 2005; Trull, Sher, MinksBrown, Durbin, & Burr, 2000) , resulting in more severe symptoms, frequent self-harm, and suicide attempts (Links, Heslegrave, Mitton, van Reekum, & Patrick, 1995; Zanarini, Frankenburg, Hennen, Reich, & Silk, 2004) . There is a large body of literature (for a review see Perry & Carroll, 2008) showing that this association is reciprocal.
In relation to BPD, some authors (Linehan, 1993; Martino, Caselli, Ruggiero, & Sassaroli, 2013; Martino et al., 2015; Selby, Anestis, & Joiner, 2008; Selby & Joiner, 2009 ) have suggested that problematic behaviours, such as SRADs (from the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders), may arise due to emotional and cognitive dysregulation. In other words the use of substances to alter mental state may become habitual (through their negative reinforcement properties) and lead to the development of SRAD. Longer term, however, the presence of SRAD will typically bring a reduction in the ability to control behaviours, enhancing the likelihood of impulsivity and aggression.
On the basis of these considerations and in line with previous theoretical models (Linehan, 1993; Selby & Joiner, 2009; Selby et al., 2008) we hypothesised the following:
• Impulsivity and aggression would be higher in BPD and SRAD (dual diagnosis, DD) compared with other personality disorders (OPDs) or BPD only.
• A BPD diagnosis would predict impulsivity and aggression and this relationship would be mediated by SRAD.
For the purposes of the present study, we defined impulsivity according to Barratt's theory (Patton, Stanford, & Barratt, 1995) . This construct is focused on clinical features of impulsivity and it is composed of three different factors (behavioural impulsivity; cognitive impulsivity; non-planning impulsivity). It describes difficulties in (1) planning future activities; (2) postponing pleasant reinforcement despite negative consequences or in favour of a more pleasant but later stimulus; and (3) choosing effective behaviours in favour of impulsive actions regarding choices or life changing.
Methods Participants
A total of 92 cases with a diagnosis of personality disorder (PD) who had accessed the Bologna Community Mental Health Centre over a one year period were offered the opportunity to take part in a study. Potential participants were evaluated through a comprehensive assessment procedure described in previous studies (Chiesa et al., 2010; Martino et al., 2012; Pozzi, Ridolfi, Daniel, Manganaro, & Berardi, 2008) . All patients had to be at least 18 years old and meet criteria for PDs. Exclusion criteria were the presence of intellectual disability, severe psychotic symptoms, and reported difficulties in understanding written or spoken Italian language.
Patients who met the above criteria were informed about the study and provided a consent form. The study was described to all participants as an investigation of their personality and other clinical features (substance use, aggression, impulsivity). Patients were also informed that after their initial evaluation they would be 212 given feedback and outlines of proposed treatments. All participants were informed that data were to be anonymised and that participation in the research project was voluntary. Informed consent, for participating in the study, was obtained from all patients included in the study. The study was approved by the Ethical Committee of the Bologna Local Health Unit.
Patients who were selected for the present study were evaluated through a sociodemographic form and a psychometric assessment package, composed of (1) the Structured Clinical Diagnostic Interview for DSM-IVAxis II (SCID II) (First, Gibbon, Spitzer, Williams, & Benjamin, 1997) ; (2) the Aggression Questionnaire (AQ) (Buss & Perry, 1992; Fossati, Maffei, Acquarini, & Di Ceglie, 2003) ; and (3) the Barratt Impulsiveness Scale (BIS-11) (Fossati, Di Ceglie, Acquarini, & Barratt, 2001) . Clinical interviews (SCID-II) were conducted by trained psychiatric physicians, all of whom have extensive experience assessing PDs.
The final sample included 80 participants: (1) 27 patients with BPD only, without current SRAD; (2) 26 patients with BPD and current SRAD (DD); and (3) 27 patients with OPD that did not meet lifetime diagnostic criteria for BPD or SRAD. Patients with SRAD reported current use of alcohol (n = 6), sedatives (n = 4), opiates (n = 4), marijuana (n = 7), amphetamine (n = 2), and cocaine/crack (n = 3). The OPD group was composed of 6 patients with Cluster A PD (1 schizoid, 3 schizotypal, 2 paranoid), 10 patients with a Cluster B PD (5 narcissistic, 5 histrionic), 9 patients with Cluster C PD (4 Avoidant, 2 Obsessive Compulsive, 3 Dependent) and 2 with a PD not otherwise specified (PDNOS). No antisocial patients were referred to the study. The majority of the patients were female (n = 68; 85%) and the mean age was 36.6 years (SD = 11.08 years). Regarding marital status, patients were mostly single (n = 46; 57.5%). There were no gender differences in substances use, and participants with a SRAD were 22 females (32% of female sample) and 4 males (33% of male sample). Males showed higher scores for both impulsivity (mean = 47.6 versus mean = 44.3) and aggression (mean = 98.2 versus mean = 81.1) compared with females.
Measures

Aggression Questionnaire
The AQ (Fossati et al., 2003 ) is a 29-item Likert-type, self-report questionnaire which measures four components of aggressiveness: (1) physical aggression (e.g., "Given enough provocation, I may hit another person" or "I get into fights a little more than the average person"); (2) verbal aggression (e.g., "I can't help getting into arguments" or "I often find myself disagreeing with people"; (3) anger (e.g., "Sometimes I fly off the handle for no good reason" or "I sometimes feel like a powder keg ready to explode"); and (4) hostility (e.g., "I wonder why sometimes I feel so bitter about things" or "At times I feel I have gotten a raw deal out of life"). The total score for all subscales was used to measure an overall tendency to aggression with higher scores indicating higher levels of aggression. In the current study the AQ Cronbach's alpha was .88.
The Barratt Impulsiveness Scale-11
The BIS-11 (Patton et al., 1995 ) is a 30-item, Likert-type, self-report questionnaire, which measures three subtypes of impulsivity: behavioural impulsivity; cognitive impulsivity; non-planning impulsivity. The total score for all subscales was used to measure an overall tendency to impulsivity with higher scores indicating higher levels of impulsivity. In the current study the BIS-11 Cronbach's alpha was .79.
Substance-related and addictive disorders data
This was collected by the senior psychiatrist and is characterised by the intermittent, indiscriminate, and nondependent use of many substances (poly-abuse), such as alcohol, sedatives, opiates, marijuana, amphetamine, cocaine/crack. The dichotomous variable referred to the presence or absence of a current substance use behaviour.
Data analysis
Statistical analyses were carried out using SPSS version 17.0 for Windows. Gender differences were obtained using the cross tabulation and t-test analyses. Group differences on impulsivity and aggression were examined using ANOVA. When multiple comparisons were needed, Bonferroni post-hoc tests were used. Before running regression analysis, data configuration was conducted. First, correlation analyses showed significant correlations between all measures (aggression, impulsivity, and SRAD). Subsequently, an inspection of graphical distribution of D2 on Q-Q plots for each variable indicated a multivariate normal distribution. We then examined multicollinearity using the tolerance index (Ti) and the variance inflation factor (VIF) for all variables. This was as follows: borderline personality disorder index (Ti = 0.82; VIF = 1.21) and SRAD (Ti = 0.82; VIF = 1.21). These analyses supported the absence of multicollinearity between variables. Furthermore, an inspection of correlation coefficients (Durbin-Watson index = 1.87) showed that there were no significant correlation between standardised residuals and independent variables. In order to implement a mediational analysis (Baron & Kenny, 1986; Cohen, 1988) we firstly examined the multicollinearity between variables (Ti = 0.75; VIF = 1.32). Subsequently we implemented linear regression analysis in order to test the hypothesis. We ran the first hierarchical regression analysis with behavioural impulsivity as the dependent variable to analyse the mediational effect of SRAD on the relationship between BPD diagnosis and behavioural impulsivity. Furthermore we ran a second hierarchical regression analysis with aggression as the dependent variable to verify the role of SRAD in mediating the relationship between BPD diagnosis and aggressive behaviour. Finally, the Sobel test was administered to ascertain the significance of the mediational models.
Results
Data showed significant differences in impulsivity and aggression between the three groups (BPD, DD, OPD) (see Table 1 ). Regarding aggression proneness, the DD group showed an overall higher score compared with the BPD group (F = 9.39; p < .001). Patients with BPD were found to only be not more aggressive than the OPD subgroup (F = 9.39; p < .35). Regarding impulsivity, data showed a higher behavioural (F = 6.76; p < .001) and cognitive (F = 8.28; p < .001) score in DD patients compared with BPD patients. In addition, BPD patients were the only group who did not show greater impairment in cognitive (F = 8.28; p < 1.00) and behavioural (F = 6.76; p < 1.00) impulsivity compared with the OPD group. No differences were found in the decision-making component of impulsivity among the three groups (F = 1.56; p < .22).
Hierarchical regression analyses
In the first hierarchical regression analysis (see Table 2 ), BPD diagnosis was entered as an independent variable and it was found to be a significant predictor of behavioural impulsivity (dependent variable). Subsequently, SRAD variable was added to the second step of this analysis. As SRAD had a significant effect on impulsivity and BPD diagnosis lost its impact on the dependent variable (in the second step of regression), this would confirm that SRAD plays a full mediating role between BPD diagnosis and impulsivity. The Sobel test was also statistically significant (z = 3.20, p < .01) confirming the mediation of SRAD in the relationship between BPD diagnosis and impulsivity (see Fig. 1 ).
In the second hierarchical regression analysis model (see Table 3 ), BPD diagnosis was as an independent variable and it was found to be a significant predictor of aggression (dependent variable). Subsequently, SRAD was added to the second step of this analysis. As SRAD had a significant effect on aggression and the BPD diagnosis lost its impact on the dependent variable (in the second step of regression), this would confirm that SRAD plays a full mediating role between BPD diagnosis and aggression. The Sobel test showed that the indirect effect of the independent variable on the dependent variable was significant (z = 3.39; p < .01), thus supporting a mediating effect (see Fig. 2 ).
In order to further test our hypotheses, we implemented two hierarchical logistic regression analyses with SRAD as dependent variable and BPD diagnosis (step 1) and impulsivity and aggression (step 2) as predictor variables. In the first regression model BPD diagnosis predicted SRAD (R 2 = .33; β = .58; p = .00). When impulsivity was inserted on the second step, however, BPD diagnosis still remained significant in predicting SRAD, whilst impulsivity did not add significant variance to the relationship (R 2 = .32; β = .01.; p = .93). Conversly, when aggression was added to the second step of the second regression model, it showed to have an impact on SRAD (R 2 = .37; β = .24; p = .01) but BPD diagnosis did not lose its significant effect in predicting SRAD. Thus, even though aggression was found to have a significant impact on SRAD it was not a mediator in this model. 
Discussion
The present study focused on the influence that SRAD have in determining impulsivity and aggressive behaviours in people with BPD. First, we explored gender differences in impulsivity and aggression and substance use behaviours. Even though impulsivity and aggression were found to be higher in males, in accordance with previous findings (Zlotnick, Rothschild, & Zimmerman, 2002) , there were no significant differences between male and female in substance use behaviours. This finding needs further investigation, considering the small male sample (n = 4) which participated in our study. Second, we examined the presence of impulsivity and BPD, borderline personality disorder; SRAD, substance-related and addictive disorders. aggression in people with BPD only, BPD and SRAD, and OPD. Our findings did not show that patients with BPD scored higher than OPD patients on impulsivity and aggressive behaviour, because no significant group differences emerged on these measures. The absence of significant group differences between BPD and OPD patients could also be due to the presence of patients with other Cluster B PDs (histrionic and narcissistic) within the OPD sample, characterised by, as well as BPD patients, higher levels of impulsivity and aggressive behaviours compared with OPDs. However, interestingly, data showed significant group differences between patients with BPD only and patients with BPD and concurrent SRAD (DD), on both measures of aggression and impulsivity (cognitive and behavioural). These results indicate that BPD patients do not show more impulsivity and aggressive behaviour compared to patients with OPDs (at least on self-report measures), but when having a comorbidity with SRAD, these features are significantly higher. Therefore, it can be hypothesised that impulsivity and aggressive behaviour are aggravated by SRAD, rather than being core features of BPD. There are indeed some studies suggesting that problematic substance use may render the psychopathology and clinical outcomes of BPD more serious. For example, problematic substance use can contribute to several BPD criteria, including dissociation, affective instability, impulsivity, and interpersonal problems (Carpenter, Wood, & Trull, 2015) . Links et al. (1995) have also found that individuals with both BPD and SRAD displayed more severe BPD psychopathology, including self-destructive and suicidal tendencies at 7-year follow-up, relative to those whose initial diagnosis was BPD or SRAD only. Another study reported that young BPD patients with comorbid SRAD were more impulsive than BPD patients without any history of SRAD (Wilson et al., 2007) .
In conclusion, our data support evidence showing how SRAD may exacerbate symptoms in BPD patients. Furthermore, the present findings confirmed that SRAD emerges as a mediating factor between both BPD diagnosis and impulsivity, and BPD and aggressive behaviour. These results highlight how a problematic use of substances may foster impulsive and uncontrolled behaviour in people with BPD. Even though impulsivity and aggression are often present in BPD patients they may not have a direct impact on substance use, but they may drive other problematic behaviours (such as self-harm or binge eating). From our findings we can argue that impulsivity and aggression may have an impact on SRAD, but it may well be that other components (such as emotional dysregulation, or rumination) of a BPD diagnosis could be superior predictors of SRAD. Conversely, the problematic use of substances in our sample showed an increased score on impulsivity and aggression and had a role in mediating the relationship between BPD diagnosis and impulsive and aggressive behaviours.
Some authors (Fossati, Gratz, Maffei, & Borroni, 2014; Sebastian et al., 2013) support the idea that impulsive behaviours in BPD might also depend on emotional dysregulation rather than solely on impulsive traits. Negative emotions might differentially affect certain components of impulse control which might account for the heterogeneous findings. Research conducted by Axelord and colleagues (Axelrod, Perepletchikova, Holtzman, & Sinha, 2011) , in support of this view, found that 
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© 2017 The Australian Psychological Society improvement in emotion regulation in BPD patients, following dialectical-behavioral therapy (Lee, Cameron, & Jenner, 2015) , accounted for improvement in impulsive and maladaptive behaviour (substance use). Therefore, future studies should include specific tools for assessing emotional dysregulation in order to confirm the influence of this process on the emergence of SRAD and problematic behaviours.
There are some limitations that should be considered when interpreting the findings from our study. First, self-report biases, context effects and poor recall may have contributed to errors in self-report measurements. Future research should pair behavioural measures with self-reported affect to confirm the impulsive and aggressive tendencies. Another limitation to this study was that it was cross-sectional and did not explore the development of disorders over time; thus future studies with a longitudinal methodology are needed in order to confirm the role of SRAD as a mediator between BPD diagnosis and increased impulsivity and aggression. Furthermore the assessment of SRAD has been collected through a clinical interview. Using a psychometric measure or objective data may help corroborate findings. Furthermore people with SRAD have not been differentiated considering the types of substances and severity of their abusing behaviour. Therefore, future research should take into account this difference. Finally, emotional dysregulation, an important component that may drive to substance use in BPD, has not been assessed in the present study. Future research should assess emotional dysregulation to verify if impulsivity may be a dependent consequence of it in order to provide potential targets for therapy and a clear understanding of mechanisms of change.
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
